https://www.avient.com/sites/default/files/2024-08/Avient-2023-Sustainability-Report_6.pdf
Chemical Mfg.
Regulations related to chemicals are also evolving globally.
Many other countries are following suit on the EU REACH chemicals regulation or a similar framework.
https://www.avient.com/sites/default/files/2021-08/avient-cdp-climate-change-questionnaire-2021.pdf
Financial control C-CH0.7 (C-CH0.7) Which part of the chemicals value chain does your organization operate in?
Row 1 Bulk organic chemicals Bulk inorganic chemicals Other chemicals Other, please specify Polymer Compounding C1.
C-CH9.6a (C-CH9.6a) Provide details of your organization’s investments in low-carbon R&D for chemical production activities over the last three years.
https://www.avient.com/products/polymer-colorants/liquid-color-concentrates-and-dosing
Formulations are tailored to be fully compatible with the chosen polymer
Excelite™ Chemical Foaming Additives
Hydrocerol™ Chemical Foaming Agents
https://www.avient.com/sites/default/files/resources/PolyOne%25202013%2520Annual%2520Report.pdf
Group Vice President, Nalco Chemical Company (a manufacturer of specialty chemicals, services and systems) from December 1999 to October 2002.
President, Specialty & Fine Chemicals — Cambrex Corporation (a specialty chemical and pharmaceutical business) August 1994 to November 2000.
The S&P Mid Cap 400 Chemicals index includes a broad range of chemical manufacturers.
https://www.avient.com/sites/default/files/resources/PolyOne%2520Proxy%2520Statement%25202016.pdf
Lorraine Age: 70 Director Since: 2008 Retired Senior Vice President and Chief Financial Officer of Eastman Chemical Company, a specialty chemicals company.
Powell Age: 70 Director Since: 2008 Retired Chairman and Chief Executive Officer of National Starch and Chemical Company, a specialty chemicals company.
Eastman Chemical Company RPM International Inc.
https://www.avient.com/knowledge-base/article/thermoplastic-elastomer-tpe-faqs?rtype[]=1164
USP specifications cover blood and body fluid compatibility/contact applications.
Thermoset Elastomers undergo a chemical change during processing to become permanently insoluble and infusible.
It is this chemical cross-linking that is the principal difference between thermoset and thermoplastic systems.
https://www.avient.com/knowledge-base/article/thermoplastic-elastomer-tpe-faqs
USP specifications cover blood and body fluid compatibility/contact applications.
Thermoset Elastomers undergo a chemical change during processing to become permanently insoluble and infusible.
It is this chemical cross-linking that is the principal difference between thermoset and thermoplastic systems.
https://www.avient.com/products/polymer-colorants/high-temperature-color-concentrates
Excelite™ Chemical Foaming Additives
Hydrocerol™ Chemical Foaming Agents
Compatible with normal PTFE extrusion processes, add color to PTFE parts
https://www.avient.com/products/polymer-additives/electrical-performance-additives
Chemical & Corrosion Resistant Formulations
Excelite™ Chemical Foaming Additives
Hydrocerol™ Chemical Foaming Agents
https://www.avient.com/sites/default/files/2021-06/avient-ir-presentation-may-2021-w-non-gaap-recs.pdf
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 26 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 4 3 3 3 4 4 5 5 5 6 7 7 8 24 A vi en t A vi en t (E xc l.
D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?